These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10419519)

  • 21. The critical role of a solvent-exposed residue of an MHC class I-restricted peptide in MHC-peptide binding.
    Huard R; Dyall R; Nikolić-Zugić J
    Int Immunol; 1997 Nov; 9(11):1701-7. PubMed ID: 9418131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allele-selective effect of PA28 in MHC class I antigen processing.
    Yamano T; Sugahara H; Mizukami S; Murata S; Chiba T; Tanaka K; Yui K; Udono H
    J Immunol; 2008 Aug; 181(3):1655-64. PubMed ID: 18641301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.
    Serwold T; Shastri N
    J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteolysis and class I major histocompatibility complex antigen presentation.
    York IA; Goldberg AL; Mo XY; Rock KL
    Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
    Sijts A; Zaiss D; Kloetzel PM
    Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
    Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
    J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
    Chen W; Khilko S; Fecondo J; Margulies DH; McCluskey J
    J Exp Med; 1994 Oct; 180(4):1471-83. PubMed ID: 7523572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing.
    Yamano T; Mizukami S; Murata S; Chiba T; Tanaka K; Udono H
    J Biol Chem; 2008 Oct; 283(42):28060-5. PubMed ID: 18703510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH.
    Chefalo PJ; Harding CV
    J Immunol; 2001 Aug; 167(3):1274-82. PubMed ID: 11466343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL.
    Gonciarz-Swiatek M; Rechsteiner M
    Mol Immunol; 2006 May; 43(12):1993-2001. PubMed ID: 16423396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of proline residue for efficient production of MHC class I ligands by proteasomes.
    Shimbara N; Ogawa K; Hidaka Y; Nakajima H; Yamasaki N; Niwa S; Tanahashi N; Tanaka K
    J Biol Chem; 1998 Sep; 273(36):23062-71. PubMed ID: 9722532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 26S proteasome degrades mouse and yeast ornithine decarboxylase in yeast cells.
    Mamroud-Kidron E; Kahana C
    FEBS Lett; 1994 Dec; 356(2-3):162-4. PubMed ID: 7805829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate.
    Murakami Y; Matsufuji S; Tanaka K; Ichihara A; Hayashi S
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):305-8. PubMed ID: 8216232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products.
    Qian SB; Reits E; Neefjes J; Deslich JM; Bennink JR; Yewdell JW
    J Immunol; 2006 Jul; 177(1):227-33. PubMed ID: 16785518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
    Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol.
    Wilk S; Chen WE; Magnusson RP
    Arch Biochem Biophys; 1999 Feb; 362(2):283-90. PubMed ID: 9989937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.
    Cascio P; Hilton C; Kisselev AF; Rock KL; Goldberg AL
    EMBO J; 2001 May; 20(10):2357-66. PubMed ID: 11350924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.
    Gil-Torregrosa BC; Raúl Castaño A; Del Val M
    J Exp Med; 1998 Sep; 188(6):1105-16. PubMed ID: 9743529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.